{"id":46701,"date":"2022-07-28T18:01:48","date_gmt":"2022-07-28T16:01:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/"},"modified":"2022-07-28T18:01:48","modified_gmt":"2022-07-28T16:01:48","slug":"hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/","title":{"rendered":"Hereditary Angioedema Epidemiology Forecast to 2032 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4410578\/hereditary-angioedema-epidemiology-forecast-to?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=jt3744&amp;utm_campaign=1732157+-+Hereditary+Angioedema+Epidemiology+Forecast+to+2032&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThis &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Hereditary Angioedema epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.\n<\/p>\n<p>\n<strong>Geographies Covered<\/strong>\n<\/p>\n<ul>\n<li>\nThe United States\n<\/li>\n<li>\nEU5 (Germany, France, Italy, Spain, and the United Kingdom)\n<\/li>\n<li>\nJapan\n<\/li>\n<\/ul>\n<p>\n<strong>Study Period:<\/strong> 2019-2032\n<\/p>\n<p>\n<strong>Hereditary Angioedema Understanding<\/strong>\n<\/p>\n<p>\nThe Hereditary Angioedema epidemiology report gives a thorough understanding of the Hereditary Angioedema by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Hereditary Angioedema in the US, Europe, and Japan. The report covers the detailed information of the Hereditary Angioedema epidemiology scenario in seven major countries (US, EU5, and Japan).\n<\/p>\n<p>\n<strong>Hereditary Angioedema Epidemiology Perspective<\/strong>\n<\/p>\n<p>\nThe Hereditary Angioedema epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Hereditary Angioedema epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Hereditary Angioedema epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.\n<\/p>\n<p>\n<strong>Hereditary Angioedema Detailed Epidemiology Segmentation<\/strong>\n<\/p>\n<p>\nThe Hereditary Angioedema epidemiology covered in the report provides historical as well as forecasted Hereditary Angioedema epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.\n<\/p>\n<p>\nThe Hereditary Angioedema report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.\n<\/p>\n<p>\n<strong>Scope of the Report<\/strong>\n<\/p>\n<ul>\n<li>\nThe Hereditary Angioedema report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns\n<\/li>\n<li>\nThe Hereditary Angioedema Epidemiology Report and Model provide an overview of the global trends of Hereditary Angioedema in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)\n<\/li>\n<li>\nThe report provides insight into the historical and forecasted patient pool of Hereditary Angioedema in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan\n<\/li>\n<li>\nThe report helps recognize the growth opportunities in the 7MM for the patient population\n<\/li>\n<li>\nThe report assesses the disease risk and burden and highlights the unmet needs of Hereditary Angioedema\n<\/li>\n<li>\nThe report provides the segmentation of the Hereditary Angioedema epidemiology\n<\/li>\n<\/ul>\n<p>\n<strong>Report Highlights<\/strong>\n<\/p>\n<ul>\n<li>\n11-year Forecast of Hereditary Angioedema epidemiology\n<\/li>\n<li>\n7MM Coverage\n<\/li>\n<li>\nPrevalent and Diagnosed Cases of Hereditary Angioedema\n<\/li>\n<li>\nCases of Hereditary Angioedema by Mutation Types\n<\/li>\n<li>\nHereditary Angioedema Cases associated with Clinical Manifestations\n<\/li>\n<\/ul>\n<p>\n<strong>Key Assessments<\/strong>\n<\/p>\n<ul>\n<li>\nPatient Segmentation\n<\/li>\n<li>\nDisease Risk &amp; Burden\n<\/li>\n<li>\nRisk of disease by the segmentation\n<\/li>\n<li>\nFactors driving growth in a specific patient population\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1. Key Insights<\/strong>\n<\/p>\n<p>\n<strong>2. Executive Summary of Hereditary Angioedema<\/strong>\n<\/p>\n<p>\n<strong>3. Hereditary Angioedema: Disease Background and Overview<\/strong>\n<\/p>\n<p>\n<strong>4. Patient Journey<\/strong>\n<\/p>\n<p>\n<strong>5. Epidemiology and Patient Population<\/strong>\n<\/p>\n<p>\n<strong>6. Treatment Algorithm, Current Treatment, and Medical Practices<\/strong>\n<\/p>\n<p>\n<strong>7. KOL Views<\/strong>\n<\/p>\n<p>\n<strong>8. Unmet Needs<\/strong>\n<\/p>\n<p>\n<strong>9. Appendix<\/strong>\n<\/p>\n<p>\n<strong>10. Publisher Capabilities<\/strong>\n<\/p>\n<p>\n<strong>11. Disclaimer<\/strong>\n<\/p>\n<p>\n<strong>12. About the Publisher<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/4410578\/hereditary-angioedema-epidemiology-forecast-to?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=jt3744&amp;utm_campaign=1732157+-+Hereditary+Angioedema+Epidemiology+Forecast+to+2032&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/mcd0mc<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x65;&#115;&#x73;&#64;&#x72;e&#x73;e&#x61;r&#x63;h&#x61;n&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#114;&#101;&#115;&#101;arch&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#107;&#101;&#116;&#115;&#46;com<\/a><\/p>\n<p>For E.S.T. Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Hereditary Angioedema epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-46701","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hereditary Angioedema Epidemiology Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hereditary Angioedema Epidemiology Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Hereditary Angioedema epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-07-28T16:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hereditary Angioedema Epidemiology Forecast to 2032 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-07-28T16:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/\"},\"wordCount\":601,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005843\\\/en\\\/1528339\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/\",\"name\":\"Hereditary Angioedema Epidemiology Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005843\\\/en\\\/1528339\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-07-28T16:01:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005843\\\/en\\\/1528339\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220728005843\\\/en\\\/1528339\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hereditary Angioedema Epidemiology Forecast to 2032 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hereditary Angioedema Epidemiology Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Hereditary Angioedema Epidemiology Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. This &#8220;Hereditary Angioedema &#8211; Epidemiology Forecast to 2032&#8221; report delivers an in-depth understanding of the disease, historical and forecasted Hereditary Angioedema epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-07-28T16:01:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hereditary Angioedema Epidemiology Forecast to 2032 &#8211; ResearchAndMarkets.com","datePublished":"2022-07-28T16:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/"},"wordCount":601,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/","name":"Hereditary Angioedema Epidemiology Forecast to 2032 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg","datePublished":"2022-07-28T16:01:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220728005843\/en\/1528339\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hereditary-angioedema-epidemiology-forecast-to-2032-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hereditary Angioedema Epidemiology Forecast to 2032 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46701","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=46701"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/46701\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=46701"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=46701"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=46701"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}